...
首页> 外文期刊>The Journal of extra-corporeal technology >Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis.
【24h】

Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis.

机译:血栓造影显示尽管进行了适当的止血,但体外循环手术后,凝血酶的产生潜力仍在继续恶化。

获取原文
获取原文并翻译 | 示例

摘要

The intrinsic and extrinsic activation pathways of the hemostatic system converge when prothrombin is converted to thrombin. The ability to generate an adequate thrombin burst is the most central aspect of the coagulation cascade. The thrombin-generating potential in patients following cardiopulmonary bypass (CPB) may be indicative of their hemostatic status. In this report, thrombography, a unique technique for directly measuring the potential of patients' blood samples to generate adequate thrombin bursts, is used to characterize the coagulopathic profile in post-CPB patients. Post-CPB hemostasis is typically achieved with protamine reversal of heparin anticoagulation and occasionally supplemented with blood product component transfusions. In this pilot study, platelet poor plasma samples were derived from 11 primary cardiac surgery patients at five time points: prior to CPB, immediately post-protamine, upon arrival to the intensive care unit (ICU), 3 hours post-ICU admission, and 24 hours after ICU arrival. Thrombography revealed that the Endogenous Thrombin Potential (ETP) was not different between [Baseline] and [PostProtamine] but proceeded to deteriorate in the immediate postoperative period. At the [3HourPostICU] time point, the ETP was significantly lower than the [Baseline] values, 1233 +/- 591 versus 595 +/- 379 nM.min (mean +/- SD; n=9, p < .005), despite continued adequacy of hemostasis. ETPs returned to baseline values the day after surgery. Transfusions received, conventional blood coagulation testing results, and blood loss volumes are also presented. Despite adequate hemostasis, thrombography reveals an underlying coagulopathic process that could put some cardiac surgical patients at risk for postoperative bleeding. Thrombography is a novel technique that could be developed into a useful tool for perfusionists and physicians to identify coagulopathies and optimize blood management following CPB.
机译:当凝血酶原转化为凝血酶时,止血系统的内在和外在激活途径会收敛。产生足够的凝血酶爆发的能力是凝血级联反应的最主要方面。体外循环(CPB)后患者中凝血酶的产生潜力可能表明其止血状态。在本报告中,血栓造影是一种直接测量患者血液样本产生足够的凝血酶爆发潜能的独特技术,用于表征CPB后患者的凝血病理特征。 CPB后止血通常通过鱼精蛋白逆转肝素抗凝来实现,偶尔补充输血产品。在这项先导研究中,血小板贫血的血浆样本来自以下五个时间点的11位原发性心脏手术患者:CPB之前,鱼精蛋白后立即,到达重症监护病房(ICU),ICU入院3小时后以及重症监护病房抵达后24小时。血栓造影显示[基线]和[鱼精蛋白]之间的内源性凝血酶潜能(ETP)没有差异,但在术后即刻恶化。在[3HourPostICU]时间点,ETP显着低于[基线]值,即1233 +/- 591与595 +/- 379 nM.min(平均值+/- SD; n = 9,p <.005) ,尽管止血效果仍然足够。手术后第二天,ETP恢复到基线值。还介绍了收到的输血,常规凝血测试结果以及失血量。尽管有足够的止血效果,但血栓造影仍显示出潜在的凝血病过程,可能使某些心脏外科手术患者面临术后出血的风险。血栓造影术是一种新颖的技术,可以发展成对灌注师和医生来说有用的工具,以识别凝血病并优化CPB后的血液管理。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号